About Index Trending news
Lists
Pricing
AOBiome

AOBiome

AOBiome

Pioneering bacterial therapy for the skin through topical applications of the patented Ammonia Oxidizing Bacteria. Buy the AO+Mist on our site

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding Show all
Venture capital (Series C)
$30,000,000
Venture capital (Series B)
$7,500,000
Employees

Team size

2
Locations
HQ
$30,000,000 Venture capital (Series C)
biospace

AOBiome Partners With iCarbonX And Secures 30 Million Investment For Drug Development